Search
for
Sort by
Research 451–480 of 1000+
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Hypoxia-Derived Mesenchymal Stem Cell Exosomes Downregulate CXCL12 and Upregulate IL-10 Expression in a Murine Model of Androgenic Alopecia
- Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Evaluating the Role of Thyroid Stimulating Hormone and Ferritin Levels with Hair Loss among Patients with COVID-19: Case-Control Study
- Genetic Single Nucleotide Polymorphisms of IL-16 and its Concentration of Patients Infected with Alopecia Areata in Diyala Province, Iraq
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia
- What causes hidradenitis suppurativa ?—15 years after
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Egr-1 is main key regulator in IL-17F-induced psoriasin expression in human keratinocytes
- Ectodysplasin-A2 induces dickkopf 1 expression in human balding dermal papilla cells overexpressing the ectodysplasin A2 receptor
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Chapter 17. Selective androgen receptor modulators (SARMs)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- COVID-19 infection leading to acute pustular dermatoses
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- Expression of NAD+dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- COVID‐19, androgens, and androgenic alopecia
- Induction of synapse associated protein 102 expression in cyclosporin A-stimulated hair growth
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Dermatological Manifestations of COVID-19: A Brief Review
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient